BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CREB1, ENSG00000118260, 1385
31 results:

  • 1. DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid leukemia.
    Sun H; Ren Y; Zhou X; Chen Q; Liu Y; Zhu C; Ruan Y; Ruan H; Tong H; Ying S; Lin P
    Technol Cancer Res Treat; 2023; 22():15330338231207765. PubMed ID: 37872685
    [No Abstract]    [Full Text] [Related]  

  • 2. The lncRNA expression profile signature of leukemia stem cells is altered upon PI3K/mTOR inhibition: an
    Kayabasi C; Gunduz C
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(2):99-115. PubMed ID: 37470414
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma.
    Cottini F; Rodriguez J; Hughes T; Sharma N; Guo L; Lozanski G; Liu B; Cocucci E; Yang Y; Benson D
    Mol Cancer Res; 2022 Jul; 20(7):1083-1095. PubMed ID: 35380709
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors.
    Vanoli F; Meskauskaite B; Herviou L; Mallen W; Sung YS; Fujisawa Y; Zhang L; Simon S; Huangfu D; Jasin M; Antonescu CR
    Oncogene; 2021 Aug; 40(32):5095-5104. PubMed ID: 34193943
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
    Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
    BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeted RNA-Sequencing Enables Detection of Relevant Translocations and Single Nucleotide Variants and Provides a Method for Classification of Hematological Malignancies-RANKING.
    de Lange K; de Boer EN; Bosga A; Alimohamed MZ; Johansson LF; Mulder AB; Vellenga E; van Diemen CC; Deelen P; van den Berg E; Sikkema-Raddatz B
    Clin Chem; 2020 Dec; 66(12):1521-1530. PubMed ID: 33257979
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Germline DDX41 mutations define a significant entity within adult MDS/AML patients.
    Sébert M; Passet M; Raimbault A; Rahmé R; Raffoux E; Sicre de Fontbrune F; Cerrano M; Quentin S; Vasquez N; Da Costa M; Boissel N; Dombret H; Peffault de Latour R; Socié G; Itzykson R; Fenaux P; Soulier J; Adès L; Clappier E
    Blood; 2019 Oct; 134(17):1441-1444. PubMed ID: 31484648
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
    Guo Y
    Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia.
    Rodríguez-Malavé NI; Fernando TR; Patel PC; Contreras JR; Palanichamy JK; Tran TM; Anguiano J; Davoren MJ; Alberti MO; Pioli KT; Sandoval S; Crooks GM; Rao DS
    Mol Cancer; 2015 Dec; 14():214. PubMed ID: 26694754
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA.
    Chae HD; Mitton B; Lacayo NJ; Sakamoto KM
    Leukemia; 2015 Jun; 29(6):1379-89. PubMed ID: 25541153
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
    Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
    Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Suspected leukemia oncoproteins creb1 and LYL1 regulate Op18/STMN1 expression.
    San-Marina S; Han Y; Liu J; Minden MD
    Biochim Biophys Acta; 2012; 1819(11-12):1164-72. PubMed ID: 23000483
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort.
    Ghassemifar R; Thien CB; Finlayson J; Joske D; Cull GM; Augustson B; Langdon WY
    Pathology; 2011 Apr; 43(3):261-5. PubMed ID: 21436637
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.
    Hu YL; Fong S; Ferrell C; Largman C; Shen WF
    Mol Cell Biol; 2009 Sep; 29(18):5181-92. PubMed ID: 19620287
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268 expression through the cAMP-responsive element-binding protein/activating transcription factor pathway.
    Wang D; Guo MX; Hu HM; Zhao ZZ; Qiu HL; Shao HJ; Zhu CG; Xue L; Shi YB; Li WX
    J Biol Chem; 2008 Jun; 283(24):16299-308. PubMed ID: 18375384
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lyl1 interacts with creb1 and alters expression of creb1 target genes.
    San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
    Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PI3-K/Akt-dependent activation of cAMP-response element-binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL.
    Caravatta L; Sancilio S; di Giacomo V; Rana R; Cataldi A; Di Pietro R
    J Cell Physiol; 2008 Jan; 214(1):192-200. PubMed ID: 17579344
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cyclic nucleotide Response Element Binding protein (CREB) activation promotes survival signal in human K562 erythroleukemia cells exposed to ionising radiation/etoposide combined treatment.
    Cataldi A; di Giacomo V; Rapino M; Genovesi D; Rana RA
    J Radiat Res; 2006 Jun; 47(2):113-20. PubMed ID: 16819137
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impaired CREB-1 phosphorylation in antifolate-resistant cell lines with down-regulation of the reduced folate carrier gene.
    Rothem L; Stark M; Assaraf YG
    Mol Pharmacol; 2004 Dec; 66(6):1536-43. PubMed ID: 15340044
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Regulation of MHC class II expression in human T-cell malignancies.
    Holling TM; Schooten E; Langerak AW; van den Elsen PJ
    Blood; 2004 Feb; 103(4):1438-44. PubMed ID: 14563641
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.